Covid-19 vaccine: Sputnik V to undergo trial in India, Dr Reddy’s gets DCGI approval

Antalya, TURKEY - August 11, 2020. The Covid-19 coronavirus vaccine produced in Russia named Sputnik-V.

After striking down the first proposal, the Drug controller General of India has finally allowed Dr Reddy’s to conduct phase 2/3 clinical human trial of Sputnik V, the Covid-19 vaccine that makes Russia the first country to have come up with a vaccine.

This will be a multi-center and randomized controlled study, which will include safety and immunogenicity study,” a joint statement issued by Dr Reddy’s and Russian Direct Investment Fund (RDIF) said.

Meanwhile, Mask Up!!
Meanwhile, Mask Up!!

Since Sputnik V was tested on a small number of people in Russia before it got registered as a vaccine, the DCGI raised questions over Dr Reddy’s initial proposal of testing it among a bigger population in India. At present, Sputnik V is currently undergoing post-registration phase 3 clinical trial engaging 40,000 participants.

In September, Dr Reddy’s and RDIF entered into a partnership to conduct clinical trials of Sputnik V vaccine and its distribution in India. As part of the partnership, India will get 100 million doses of Sputnik.

शेयर करे

Be the first to comment

Leave a Reply